Published in Blood Weekly, September 7th, 2006
According to recent research published in the journal Blood, "Bone marrow normal lymphoid progenitors (CD19+, CD10+, and/or CD34+) are exquisitely sensitive to corticosteroids and other antileukemic drugs. We hypothesized that, in patients with B-lineage ALL, cells with this phenotype detected early in treatment should be leukemic rather than normal."
"We therefore developed a simple and inexpensive flow cytometric assay for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.